Statins and Metformin Use Is Associated with Lower PSA Levels in Prostate Cancer Patients Presenting for Radiation Therapy | Zendy

Xiaonan Liu | Zendy; Jing Li | Zendy; Steven E. Schild | Zendy; Michael H. Schild | Zendy; William W. Wong | Zendy; Sujay A. Vora | Zendy; Michael Herman | Zendy; M. Fatyga | Zendy

Open Access

Statins and Metformin Use Is Associated with Lower PSA Levels in Prostate Cancer Patients Presenting for Radiation Therapy

Author(s) -

Xiaonan Liu,

Jing Li,

Steven E. Schild,

Michael H. Schild,

William W. Wong,

Sujay A. Vora,

Michael Herman,

M. Fatyga

Publication year - 2017

Publication title -

journal of cancer therapy

Language(s) - English

Resource type - Journals

eISSN - 2151-1942

pISSN - 2151-1934

DOI - 10.4236/jct.2017.82007

Subject(s) - medicine , metformin , prostate cancer , cancer , prostate specific antigen , statin , retrospective cohort study , radiation therapy , oncology , multivariate analysis , univariate analysis , urology , insulin

A possible association between the level of prostate specific antigen (PSA) and the use of some commonly prescribed medications has been reported in recent studies. Most of these studies were carried out in general populations of men who were screened for prostate cancer using the PSA test. We reported on the association between the initial PSA level and the use of statins, metformin and alpha-blockers in patients who were diagnosed with prostate cancer and presented for radiation therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research